129 related articles for article (PubMed ID: 6874293)
1. A comparative study of a number of nutritional and immunological indices in patients with skin carcinoma.
Moriarty M; O'Loughlin G; McFarlane R; Johnson A; Collins P; Mulgrew S; Conroy R; Daly L
Ir J Med Sci; 1983 Jun; 152(6):242-5. PubMed ID: 6874293
[No Abstract] [Full Text] [Related]
2. Cell-mediated immunity in patients with basal and squamous cell skin cancer.
Weimar VM; Ceilley RI; Goeken JA
J Am Acad Dermatol; 1980 Feb; 2(2):143-7. PubMed ID: 6965945
[TBL] [Abstract][Full Text] [Related]
3. T lymphocytes with Fc-IgG receptors in skin cancers.
Vena GA; Angelini G; D'Ovidio R; Lospalluti M; Meneghini CL
Acta Derm Venereol; 1981; 61(6):555-8. PubMed ID: 6177170
[No Abstract] [Full Text] [Related]
4. [The immunological characteristics of metatypic skin cancer].
Snarskaia ES
Sov Med; 1991; (7):90. PubMed ID: 1948364
[No Abstract] [Full Text] [Related]
5. Melanoma and nonmelanoma skin cancers and the immune system.
Domingo DS; Baron ED
Adv Exp Med Biol; 2008; 624():187-202. PubMed ID: 18348457
[No Abstract] [Full Text] [Related]
6. The dermal cellular infiltrate and cell-mediated immunity in skin carcinomas.
Avgerinou G; Nicolis G; Vareltzidis A; Stratigos J
Dermatologica; 1985; 171(4):238-42. PubMed ID: 4076497
[TBL] [Abstract][Full Text] [Related]
7. Multiple cutaneous carcinomas and lymphomas of the skin.
Cohen C
Arch Dermatol; 1980 Jun; 116(6):687-9. PubMed ID: 6892866
[TBL] [Abstract][Full Text] [Related]
8. [Immuno-allergological studies in skin cancer].
Michailow P; Berowa N; Kutintschev M
Hautarzt; 1966 Aug; 17(8):356-7. PubMed ID: 4965047
[No Abstract] [Full Text] [Related]
9. Multiple nonmelanoma skin cancer associated with HLA DR7 in southern Australia.
Czarnecki DB; Lewis A; Nicholson I; Tait B
Cancer; 1991 Jul; 68(2):439-40. PubMed ID: 2070340
[No Abstract] [Full Text] [Related]
10. DNCB reactivity in patients with skin carcinoma.
Bleumink E; Nater JP
Dermatologica; 1974; 148(1):44-6. PubMed ID: 4364858
[No Abstract] [Full Text] [Related]
11. Immune response to basal cell and squamous cell carcinomas.
Grimwood RE
Immunol Ser; 1989; 46():789-98. PubMed ID: 2488879
[TBL] [Abstract][Full Text] [Related]
12. [Tinea capitis due to Trichophyton rubrum and multi-morbidity in old age with partial defect of cellular immunity].
Kind R; Hornstein OP; Meinhof W; Weidner F
Hautarzt; 1974 Dec; 25(12):606-10. PubMed ID: 4448642
[No Abstract] [Full Text] [Related]
13. Antibodies to basal epidermal cells in patients with basal or squamous cell carcinoma.
Ackermann-Schopf CM
Arch Dermatol Res (1975); 1976 Dec; 257(2):149-56. PubMed ID: 1008612
[TBL] [Abstract][Full Text] [Related]
14. Reduced experimental contact sensitivity in squamous cell but not basal cell carcinomas of skin.
de Berker D; Ibbotson S; Simpson NB; Matthews JN; Idle JR; Rees JL
Lancet; 1995 Feb; 345(8947):425-6. PubMed ID: 7853955
[TBL] [Abstract][Full Text] [Related]
15. Responses of neoplasms to local immunotherapy.
Klein E; Holtermann OA; Case RW; Milgrom H; Rosner D; Adler S
Am J Clin Pathol; 1974 Aug; 62(2):281-9. PubMed ID: 4602090
[No Abstract] [Full Text] [Related]
16. [Cellular immunity in squamous-cell and basal-cell carcinomas].
Vena GA; Angelini G; D'Ovidio R; Lospalluti M; Meneghini CL
G Ital Dermatol Venereol; 1982; 117(5):263-7. PubMed ID: 6985323
[No Abstract] [Full Text] [Related]
17. Aberrant expression of Fas and FasL pro-apoptotic proteins in basal cell and squamous cell carcinomas.
Wang XY; Zhang R; Lian S
Clin Exp Dermatol; 2011 Jan; 36(1):69-76. PubMed ID: 20497185
[TBL] [Abstract][Full Text] [Related]
18. Skin cancers and HLA frequencies in renal transplant recipients.
Czarnecki D; Watkins F; Leahy S; Dyall-Smith D; Levis A; Nicholson I; Tait B
Dermatology; 1992; 185(1):9-11. PubMed ID: 1638083
[TBL] [Abstract][Full Text] [Related]
19. Antigenic differences and further perspectives on the differential diagnosis of skin tumors.
Tosca AD; Lehou J; Panagiotopoulos A; Varelzidis A; Stratigos J
J Dermatol; 1986 Oct; 13(5):366-71. PubMed ID: 2434542
[No Abstract] [Full Text] [Related]
20. p53-specific serum antibodies are not associated with a history of skin carcinoma in renal transplant recipients and immunocompetent individuals.
de Graaf YG; Schiefer D; Redeker A; Vermeer BJ; Bavinck JN; Willemze R; de Gruijl FR; Van der Burg SH
J Dermatol Sci; 2005 Jun; 38(3):228-30. PubMed ID: 15927816
[No Abstract] [Full Text] [Related]
[Next] [New Search]
